Literature DB >> 26144346

Exploration of the structure-activity relationship of 1,2,4-oxadiazole antibiotics.

Derong Ding1, Marc A Boudreau1, Erika Leemans1, Edward Spink1, Takao Yamaguchi1, Sebastian A Testero1, Peter I O'Daniel1, Elena Lastochkin1, Mayland Chang1, Shahriar Mobashery2.   

Abstract

We have recently disclosed the discovery of the class of 1,2,4-oxadiazole antibiotics, which emerged from in silico docking and scoring efforts. This class of antibacterials exhibits Gram-positive activity, particularly against Staphylococcus aureus. We define the structure-activity relationship (SAR) of this class of antibiotics with the synthesis and evaluation of a series of 59 derivatives with variations in the C ring or C and D rings. A total of 17 compounds showed activity against S. aureus. Four derivatives were evaluated against a panel of 16 Gram-positive strains, inclusive of several methicillin-resistant S. aureus strains. These compounds are broadly active against Gram-positive bacteria.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  1,2,4-Oxadiazoles; Antibiotics; Structure–activity relationship

Mesh:

Substances:

Year:  2015        PMID: 26144346      PMCID: PMC4607640          DOI: 10.1016/j.bmcl.2015.06.044

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  11 in total

Review 1.  Costs of healthcare-associated methicillin-resistant Staphylococcus aureus and its control.

Authors:  I M Gould; J Reilly; D Bunyan; A Walker
Journal:  Clin Microbiol Infect       Date:  2010-11-05       Impact factor: 8.067

Review 2.  The times they are a-changin': new antibacterials for skin and skin structure infections.

Authors:  Mai-Chi N Tran; Snezana Naumovski; Ellie J C Goldstein
Journal:  Am J Clin Dermatol       Date:  2015-06       Impact factor: 7.403

3.  Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002.

Authors:  Matthew J Kuehnert; Deanna Kruszon-Moran; Holly A Hill; Geraldine McQuillan; Sigrid K McAllister; Gregory Fosheim; Linda K McDougal; Jasmine Chaitram; Bette Jensen; Scott K Fridkin; George Killgore; Fred C Tenover
Journal:  J Infect Dis       Date:  2005-12-15       Impact factor: 5.226

4.  Synthesis and evaluation of 1,2,4-triazolo[1,5-a]pyrimidines as antibacterial agents against Enterococcus faecium.

Authors:  Huan Wang; Mijoon Lee; Zhihong Peng; Blas Blázquez; Elena Lastochkin; Malika Kumarasiri; Renee Bouley; Mayland Chang; Shahriar Mobashery
Journal:  J Med Chem       Date:  2015-05-12       Impact factor: 7.446

Review 5.  Methicillin-resistant Staphylococcus aureus: the superbug.

Authors:  Giuseppe Ippolito; Sebastiano Leone; Francesco N Lauria; Emanuele Nicastri; Richard P Wenzel
Journal:  Int J Infect Dis       Date:  2010-09-20       Impact factor: 3.623

6.  Structure-activity relationship for the oxadiazole class of antibiotics.

Authors:  Edward Spink; Derong Ding; Zhihong Peng; Marc A Boudreau; Erika Leemans; Elena Lastochkin; Wei Song; Katerina Lichtenwalter; Peter I O'Daniel; Sebastian A Testero; Hualiang Pi; Valerie A Schroeder; William R Wolter; Nuno T Antunes; Mark A Suckow; Sergei Vakulenko; Mayland Chang; Shahriar Mobashery
Journal:  J Med Chem       Date:  2015-01-30       Impact factor: 7.446

7.  Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008).

Authors:  George G Zhanel; Melanie DeCorby; Heather Adam; Michael R Mulvey; Melissa McCracken; Philippe Lagacé-Wiens; Kimberly A Nichol; Aleksandra Wierzbowski; Patricia J Baudry; Franil Tailor; James A Karlowsky; Andrew Walkty; Frank Schweizer; Jack Johnson; Daryl J Hoban
Journal:  Antimicrob Agents Chemother       Date:  2010-08-30       Impact factor: 5.191

8.  Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study.

Authors:  Laura García-Álvarez; Matthew T G Holden; Heather Lindsay; Cerian R Webb; Derek F J Brown; Martin D Curran; Enid Walpole; Karen Brooks; Derek J Pickard; Christopher Teale; Julian Parkhill; Stephen D Bentley; Giles F Edwards; E Kirsty Girvan; Angela M Kearns; Bruno Pichon; Robert L R Hill; Anders Rhod Larsen; Robert L Skov; Sharon J Peacock; Duncan J Maskell; Mark A Holmes
Journal:  Lancet Infect Dis       Date:  2011-08       Impact factor: 25.071

Review 9.  Colonization and infection of the skin by S. aureus: immune system evasion and the response to cationic antimicrobial peptides.

Authors:  Sunhyo Ryu; Peter I Song; Chang Ho Seo; Hyeonsook Cheong; Yoonkyung Park
Journal:  Int J Mol Sci       Date:  2014-05-16       Impact factor: 5.923

10.  Discovery of a new class of non-β-lactam inhibitors of penicillin-binding proteins with Gram-positive antibacterial activity.

Authors:  Peter I O'Daniel; Zhihong Peng; Hualiang Pi; Sebastian A Testero; Derong Ding; Edward Spink; Erika Leemans; Marc A Boudreau; Takao Yamaguchi; Valerie A Schroeder; William R Wolter; Leticia I Llarrull; Wei Song; Elena Lastochkin; Malika Kumarasiri; Nuno T Antunes; Mana Espahbodi; Katerina Lichtenwalter; Mark A Suckow; Sergei Vakulenko; Shahriar Mobashery; Mayland Chang
Journal:  J Am Chem Soc       Date:  2014-02-21       Impact factor: 15.419

View more
  9 in total

Review 1.  Bioactive Compounds from Marine Heterobranchs.

Authors:  Conxita Avila; Carlos Angulo-Preckler
Journal:  Mar Drugs       Date:  2020-12-21       Impact factor: 5.118

2.  Unconventional Antibacterials and Adjuvants.

Authors:  Mayland Chang; Kiran V Mahasenan; Juan A Hermoso; Shahriar Mobashery
Journal:  Acc Chem Res       Date:  2021-01-29       Impact factor: 22.384

Review 3.  The oxadiazole antibacterials.

Authors:  Jeshina Janardhanan; Mayland Chang; Shahriar Mobashery
Journal:  Curr Opin Microbiol       Date:  2016-05-27       Impact factor: 7.934

4.  Three-dimensional QSAR analysis and design of new 1,2,4-oxadiazole antibacterials.

Authors:  Erika Leemans; Kiran V Mahasenan; Malika Kumarasiri; Edward Spink; Derong Ding; Peter I O'Daniel; Marc A Boudreau; Elena Lastochkin; Sebastian A Testero; Takao Yamaguchi; Mijoon Lee; Dusan Hesek; Jed F Fisher; Mayland Chang; Shahriar Mobashery
Journal:  Bioorg Med Chem Lett       Date:  2015-12-12       Impact factor: 2.823

5.  Activities of Oxadiazole Antibacterials against Staphylococcus aureus and Other Gram-Positive Bacteria.

Authors:  Sara Ceballos; Choon Kim; Derong Ding; Shahriar Mobashery; Mayland Chang; Carmen Torres
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

6.  Metal-free hydroarylation of the side chain carbon-carbon double bond of 5-(2-arylethenyl)-3-aryl-1,2,4-oxadiazoles in triflic acid.

Authors:  Anna S Zalivatskaya; Dmitry S Ryabukhin; Marina V Tarasenko; Alexander Yu Ivanov; Irina A Boyarskaya; Elena V Grinenko; Ludmila V Osetrova; Eugeniy R Kofanov; Aleksander V Vasilyev
Journal:  Beilstein J Org Chem       Date:  2017-05-11       Impact factor: 2.883

Review 7.  A review on synthetic account of 1,2,4-oxadiazoles as anti-infective agents.

Authors:  Tejas M Dhameliya; Shrddhaba J Chudasma; Tanvi M Patel; Bhavarth P Dave
Journal:  Mol Divers       Date:  2022-01-05       Impact factor: 3.364

8.  3D-QSAR Studies of 1,2,4-Oxadiazole Derivatives as Sortase A Inhibitors.

Authors:  Neda Shakour; Farzin Hadizadeh; Prashant Kesharwani; Amirhossein Sahebkar
Journal:  Biomed Res Int       Date:  2021-12-06       Impact factor: 3.411

9.  Development of 1,2,4-Oxadiazole Antimicrobial Agents to Treat Enteric Pathogens within the Gastrointestinal Tract.

Authors:  Noel P Pitcher; Jitendra R Harjani; Yichao Zhao; Jianwen Jin; Daniel R Knight; Lucy Li; Papanin Putsathit; Thomas V Riley; Glen P Carter; Jonathan B Baell
Journal:  ACS Omega       Date:  2022-02-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.